American Diabetes Association Applauds Federal Funding for Diabetes Research and Prevention
June 15, 2012
The American Diabetes Association, the nation’s largest and leading voluntary health organization, applauds the Senate Appropriations Committee for their leadership in the fight to Stop Diabetes® by investing in critically important diabetes research and prevention programs through funding for the National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC) in the FY 2013 Labor, Health and Human Services (LHHS) Appropriations bill.
The Committee included $20 million in FY 2013 funding for the National Diabetes Prevention Program at the CDC. The additional $10 million in funding over FY 2012 levels represents a necessary increase to combat the growing number of Americans at risk for type 2 diabetes who will benefit from this important community-based program. The Committee appropriated $64.434 million for the CDC’s Division of Diabetes Translation (DDT), which is consistent with FY 2012 funding. The panel also allocated $1.947 billion in overall funding, including $150 million in Special Diabetes Program funding, for the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which is a $2.2 million increase over current year levels.
“The American Diabetes Association is proud to stand with Members of the Senate Appropriations Committee, including Chairman Daniel Inouye (D-HI) and Ranking Member Thad Cochran (R-MS), and LHHS Subcommittee Chairman Tom Harkin (D-IA) and Ranking Member Richard Shelby (R-AL), to call attention to the devastating human and economic toll diabetes is taking on our country,” said L. Hunter Limbaugh, Chair of the Board, American Diabetes Association. “While the rate of diabetes has been on the rise, the federal commitment to diabetes research and prevention programs has not kept pace. This additional funding is critical to moving towards the level we need to end this devastating disease.”
Diabetes is a growing epidemic with nearly 26 million adults and children living with diabetes in the U.S. Another 79 million have prediabetes, putting them at increased risk for developing type 2 diabetes. Diabetes, including undiagnosed and gestational diabetes, and prediabetes, costs the nation an estimated $218 billion annually and is a threat to both the health and fiscal stability of the country.
The cutting-edge research supported by the NIDDK facilitates the search for a cure and better treatments for type 1, type 2 and gestational diabetes. The DDT is leading the way in operating diabetes prevention activities across the country needed to stem the growth of the diabetes epidemic. The National Diabetes Prevention Program is a proven prevention model that promotes lifestyle change programs at the community level for people who are at high risk for type 2 diabetes. If fully implemented, the program has the ability to save our nation’s health care system billions of dollars and drastically reduce the number of people with type 2 diabetes.
“The Association is extremely grateful the Committee recognizes the importance of the National Institute of Diabetes and Digestive and Kidney Diseases and the Division of Diabetes Translation programs in changing the future of diabetes in our country. This funding will make a significant difference in the lives of individuals living with, and at risk for, diabetes,” Limbaugh said.
The American Diabetes Association is leading the fight to Stop Diabetes and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, our mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes.
For more information please call the American Diabetes Association at 1-800-DIABETES (800-342-2383) or visit www.diabetes.org. Information from both these sources is available in English and Spanish.